News25/Ratings1
News · 26 weeks42-31%
2025-12-142026-06-07
Mix3290d
- Insider15(47%)
- SEC Filings7(22%)
- Leadership3(9%)
- Other4(13%)
- Earnings2(6%)
- Dividends1(3%)
Latest news
25 items- INSIDERSEC Form 4 filed by Director Fitzgerald Charles4 - Chiron Real Estate Inc. (0001533615) (Issuer)
- SECChiron Real Estate Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits8-K - Chiron Real Estate Inc. (0001533615) (Filer)
- PRChiron Real Estate Inc. Completes Acquisition of Inaugural SHOP Communities–Inaugural Senior Housing Investments Position Company for Growth– Chiron Real Estate Inc. (NYSE:XRN) (the "Company" or "Chiron"), announced today that it has completed the previously announced acquisition of The Landing (the "Landing") and The Riviera (the "Riviera"), two premier senior living communities located in the Washington, DC MSA, from affiliates of Silverstone Senior Living ("Silverstone") for an aggregate purchase price of $249 million. "Crossing the finish line on this transaction represents a significant milestone for Chiron as we successfully enter the senior housing space," said Mark Decker, Jr., Chief Executive Officer of Chiron Real Estate Inc. "The Landing and Riviera
- PRAditxt, Inc. Appoints Jeffrey M. Busch as Interim Chief Executive Officer; Founder and Former CEO of $1B NYSE Enterprise Which Delivered ~8.5% Dividends to ShareholdersSeasoned executive who founded and built an NYSE-listed healthcare real estate company to over $1 billion in enterprise value — delivering an average dividend yield of approximately 8.5% to shareholders — brings capital markets depth, healthcare sector expertise, and commercial discipline to lead Aditxt's next chapter of revenue-driven growth. Aditxt, Inc. (NASDAQ:ADTX)("Aditxt" or the "Company"), a life sciences platform company accelerating promising health innovations, today announced the appointment of Jeffrey M. Busch as Interim Chief Executive Officer of Aditxt, Inc., effective May 31, 2026. Mr. Busch, who has served as Chief Executive Officer of Aditxt's CLIA-certified precision on
- INSIDERSEC Form 4 filed by Director Wittman Lori4 - Chiron Real Estate Inc. (0001533615) (Issuer)
- INSIDERSEC Form 4 filed by Director Fitzgerald Charles4 - Chiron Real Estate Inc. (0001533615) (Issuer)
- INSIDERSEC Form 4 filed by Director Cypher Matthew4 - Chiron Real Estate Inc. (0001533615) (Issuer)
- INSIDERSEC Form 4 filed by Director Crowley Paula4 - Chiron Real Estate Inc. (0001533615) (Issuer)
- INSIDERNew insider Fitzgerald Charles claimed ownership of 97,293 shares (SEC Form 3)3 - Chiron Real Estate Inc. (0001533615) (Issuer)
- SECChiron Real Estate Inc. filed SEC Form 8-K: Leadership Update, Entry into a Material Definitive Agreement, Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Chiron Real Estate Inc. (0001533615) (Filer)
- PRChiron Real Estate Inc. Announces Appointment of Charles Fitzgerald to its Board of Directors and the Declaration of its Second Quarter Preferred DividendsChiron Real Estate Inc. (NYSE:XRN) (the "Company" or "Chiron"), today announced the appointment of Charles Fitzgerald to the Company's Board of Directors (the "Board"), effective as of May 20, 2026, and the declaration of the Company's second quarter 2026 preferred dividends. Mr. Fitzgerald will serve as a member of the Board's Compensation and Nominating and Corporate Governance Committees. Underscoring his strong alignment with shareholder interests, Mr. Fitzgerald holds 97,293 shares of Chiron common stock via affiliated entities, representing approximately $3.4 million of invested capital. Appointment of Charles Fitzgerald to the Board Mr. Fitzgerald, age 51, is the Founder and Ma
- INSIDERDirector Cypher Matthew bought $49,874 worth of shares (1,420 units at $35.12), increasing direct ownership by 526% to 1,690 units (SEC Form 4)4 - Chiron Real Estate Inc. (0001533615) (Issuer)
- INSIDERDirector Wittman Lori bought $99,515 worth of shares (2,940 units at $33.85) (SEC Form 4)4 - Chiron Real Estate Inc. (0001533615) (Issuer)
- INSIDERDirector Marston Ronald bought $51,110 worth of shares (1,500 units at $34.07) (SEC Form 4)4 - Chiron Real Estate Inc. (0001533615) (Issuer)
- INSIDERGeneral Counsel and Secretary Barber Jamie Allen bought $49,614 worth of shares (1,481 units at $33.50) (SEC Form 4)4 - Chiron Real Estate Inc. (0001533615) (Issuer)
- INSIDERCFO and Treasurer Kiernan Robert J bought $100,470 worth of shares (3,000 units at $33.49), increasing direct ownership by 100% to 6,000 units (SEC Form 4)4 - Chiron Real Estate Inc. (0001533615) (Issuer)
- INSIDERCOO Holley Danica bought $50,645 worth of shares (1,490 units at $33.99), increasing direct ownership by 1,490% to 1,590 units (SEC Form 4)4 - Chiron Real Estate Inc. (0001533615) (Issuer)
- INSIDERCEO and President Decker Mark Okey Jr bought $169,700 worth of shares (5,000 units at $33.94), increasing direct ownership by 9% to 59,774 units (SEC Form 4)4 - Chiron Real Estate Inc. (0001533615) (Issuer)
- INSIDERDirector Crowley Paula bought $34,000 worth of shares (1,000 units at $34.00) (SEC Form 4)4 - Chiron Real Estate Inc. (0001533615) (Issuer)
- INSIDERDirector Cole Henry bought $19,998 worth of shares (583 units at $34.30) (SEC Form 4)4 - Chiron Real Estate Inc. (0001533615) (Issuer)
- SECChiron Real Estate Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits8-K - Chiron Real Estate Inc. (0001533615) (Filer)
- SECSEC Form 10-Q filed by Chiron Real Estate Inc.10-Q - Chiron Real Estate Inc. (0001533615) (Filer)
- ANALYSTChiron Real Estate downgraded by Compass Point with a new price targetCompass Point downgraded Chiron Real Estate from Buy to Neutral and set a new price target of $38.00
- SECChiron Real Estate Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Results of Operations and Financial Condition, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits8-K - Chiron Real Estate Inc. (0001533615) (Filer)
- PRChiron Real Estate Inc. Announces $100 Million Strategic Convertible Perpetual Preferred Equity Investment Led by Maewyn Capital PartnersChiron Real Estate Inc. (NYSE:XRN) (the "Company" or "Chiron"), today announced the entry into an agreement providing for up to a $100 million delayed-draw convertible perpetual preferred equity investment led by Maewyn Capital Partners ("Maewyn"). "This growth equity investment represents an important milestone in the repositioning of Chiron. Maewyn's capital provides long-term flexibility and is expected to accelerate our transition toward higher-return opportunities across the healthcare real estate spectrum. We are focused on disciplined capital allocation and believe this investment further aligns our capital structure with our objective of driving long-term earnings growth," said Ma
XRN FAQ
6 questionsWhere does XRN stock trade?
Chiron Real Estate Inc. (XRN) is listed on NYSE.What sector and industry is XRN in?
Chiron Real Estate Inc. operates in the Real Estate sector, Real Estate Investment Trusts industry.When did Chiron Real Estate Inc. go public?
Chiron Real Estate Inc. (XRN) completed its IPO in 2016.What are analysts saying about XRN?
Chiron Real Estate Inc. has had 1 recent analyst action on file. The most recent action was from Compass Point: Neutral with a $3800.00 price target on 2026-05-07. Recent price targets cluster around $3800.00.What companies are similar to XRN?
Notable peers in the same industry include WELL (Welltower Inc.), PLD (Prologis Inc.), EQIX (Equinix Inc.), AMT (American Tower Corporation (REIT)), SPG (Simon Property Group Inc.). Compare XRN side-by-side with any of them on Quantisnow.How can I track XRN on Quantisnow?
Quantisnow aggregates Chiron Real Estate Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow XRN to receive live email and push alerts on every new disclosure.